• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Chiral Technology Market 2013-2017 - Product Image

Global Chiral Technology Market 2013-2017

  • Published: September 2013
  • Region: Global
  • 48 pages
  • TechNavio

FEATURED COMPANIES

  • Bachem Holding AG
  • Cambrex Corp.
  • Daicel Corp.
  • Novasep Inc.
  • Regis Technologies Inc.
  • Solvias AG
  • MORE

The analysts forecast the Global Chiral Technology market to grow at a CAGR of 14.53 percent over the period 2013-2017. One of the key factors contributing to this market growth is the favorable governmental regulations. The Global Chiral Technology market has also been witnessing the increasing outsourcing of pharmaceutical production to the APAC Region. However, the complexity of chiral chemistry could pose a challenge to the growth of this market.

The report, the Global Chiral Technology Market 2013-2017, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, APAC region; it also covers the Global Chiral Technology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include BASF SE, Daicel Corp. Royal DSM N.V.

Other vendors mentioned in the report are Bachem Holding AG, Cambrex Corp.,Codexis Inc.,Johnson Matthey plc, Novasep Inc., Phenomenex Inc., Regis Technologies Inc., Solvias AG, Strem Chemicals Inc..

Key questions answered in this report:
- What READ MORE >

01. Executive Summary
02. Scope of the Report
02.1 Market Overview
02.2 Product Offerings
03. Market Research Methodology
03.1 Market Research Process
03.2 Research Design
03.3 Research Methodology
04. List of Abbreviations
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
06.4 Five Forces Analysis
07. Market Segmentation by Technology
07.1.1 Traditional Technology
07.1.2 2. Asymmetric Technology
07.1.3 3. Biological
07.2 Global Traditional Chiral Technology Market
07.2.1 Market Size and Forecast
07.3 Global Asymmetric Chiral Technology Market
07.3.1 Market Size and Forecast
07.4 Global Biological Chiral Technology Market
07.4.1 Market Size and Forecast
08. Geographical Segmentation
08.1 Impact of Outsourcing Drug Development Activities
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.2 Other Vendors
17. Key Vendor Analysis
17.1 BASF SE
17.1.1 Business Overview
17.1.2 Business Segmentation

17.1.3 Key Information
17.1.4 SWOT Analysis
17.2 Daicel Corp.
17.2.1 Business Overview
17.2.2 Business Segmentation
17.2.3
17.2.4 Key Information
17.2.5 SWOT Analysis
17.3 Royal DSM N.V
17.3.1 Business Overview
17.3.2 Business Segmentation
17.3.3 Key Information
17.3.4 SWOT analysis
18. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Chiral Technology Market 2013-2017 (US$ billion)
Exhibit 3: Popular Drugs
Exhibit 4: Global Chiral Technology Market Segmentation
Exhibit 5: Global Traditional Chiral Technology Market 2013-2017 (US$ billion)
Exhibit 6: Global Asymmetric Chiral Technology Market 2013-2017 (US$ billion)
Exhibit 7: Global Biological Chiral Technology Market 2013-2017 (US$ billion)
Exhibit 8: Global Chiral Technology Market Forecast by Technology 2013-2017 (percentage)
Exhibit 9: Global Chiral Technology Market by Geographical Segmentation 2013

Commenting on the report, an analyst from the team said: “Many global pharmaceutical companies are nowadays facing several challenges such as patent expirations and pricing pressures. As a result, these companies are on the lookout for cost containment measures. For instance, drug manufacturing in Asian countries is less expensive than it is in western countries. Further, the growing prominence of Asia as an end-user market and its growth in terms of manufacturing as well as human resource capabilities is expected to contribute to the growth of the market during the forecast period.”

According to the report, governmental regulations that support the use of chiral technology constitute a major driver in this market. Healthcare authorities in many countries have introduced guidelines and policies that provide incentives for investments made in developing single enantiomer drugs.

Further, the report states that one of the main challenges in this market is the complexity of chiral chemistry. The complexity of chiral chemistry is higher in the case of molecules containing multiple chiral centers. As a result, the selection of an appropriate technique for the synthesis and resolution of such molecules becomes challenging.

The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Bachem Holding AG, Cambrex Corp., Codexis Inc, Johnson Matthey plc, Novasep Inc., Phenomenex Inc., Regis Technologies Inc., Solvias AG, and Strem Chemicals Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

- BASF SE
- Daicel Corp.
- Royal DSM N.V.
- Bachem Holding AG
- Cambrex Corp.
- Codexis Inc.
- Johnson Matthey plc
- Novasep Inc.
- Phenomenex Inc.
- Regis Technologies Inc.
- Solvias AG
- Strem Chemicals Inc..

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos